TSX:AVCN - Post Discussion
Post by
Betteryear2 on Aug 27, 2024 8:13am
Avicanna Announces United States Patent
USPTO issues Patent No. US 20230025693A1 (“Patent”) that covers Avicanna’s deep penetrating topical
cannabinoid composition and methods for treating musculoskeletal inflammation and pain
TORONTO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the United States Patent and Trademark Office (“USPTO”) issuance of the Patent covering Avicanna’s deep penetrating topical cannabinoid composition and methods for treating musculoskeletal inflammation and pain.
Avicanna Announces United States Patent and Trademark (globenewswire.com)
Be the first to comment on this post